| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QLYS | Common Stock | Options Exercise | $132,894 | +6,900 | +3.8% | $19.26* | 187,878 | 31 Mar 2022 | Direct | F1 |
| transaction | QLYS | Common Stock | Sale | $1,001,420 | -6,900 | -3.7% | $145.13 | 180,978 | 31 Mar 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QLYS | Stock Option (right to buy) | Options Exercise | $0 | -6,900 | -69% | $0.000000 | 3,111 | 31 Mar 2022 | Common Stock | 6,900 | $19.26 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2021. |
| F2 | The sale price represents the weighted average price of the shares sold ranging from $145.00 to $145.4350 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F3 | This option is fully vested and immediately exercisable. |